AmerisourceBergen acquires specialty pharmaceutical services co.

VALLEY FORGE, Pa. A large pharmaceutical services company has purchased Innomar Strategies, a specialty pharmaceutical services company in Canada.

AmerisourceBergen Corp. announced Tuesday the purchase of the Toronto-based company for $13.8 million in cash.

“With Innomar Strategies and our current AmerisourceBergen Specialty Group, Canada, we believe AmerisourceBergen now has the largest and broadest commercialization service offerings to pharmaceutical and biotechnology manufacturers in Canada,” AmerisourceBergen president and CEO R. David Yost said. “This acquisition continues our strategy of acquiring companies within our pharmaceutical distribution and related services focus.”